<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2025-104-11-1545-1548</article-id><article-id custom-type="edn" pub-id-type="custom">hgmddw</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-5307</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОФИЛАКТИЧЕСКАЯ ТОКСИКОЛОГИЯ И ГИГИЕНИЧЕСКОЕ НОРМИРОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION</subject></subj-group></article-categories><title-group><article-title>Экспериментальная оценка гонадотоксичности нанокомпозита гадолиния</article-title><trans-title-group xml:lang="en"><trans-title>Experimental evaluation of gonadotoxicity of gadolinium nanocomposite</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6100-6292</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новиков</surname><given-names>Михаил Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Novikov</surname><given-names>Mikhail A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канд. биол. наук, ст. науч. сотр. лаб. биомоделирования и трансляционной медицины ФГБНУ ВСИМЭИ, 665826, Ангарск, Россия</p><p>e-mail: novik-imt@mail.ru</p></bio><bio xml:lang="en"><p>PhD (Biology), senior researcher, Laboratory of biomodeling and translational medicine, East Siberian Institute of Medical and Ecological Research, 665826, Angarsk, 665826, Russian Federation</p><p>e-mail: novik-imt@mail.ru</p></bio><email xlink:type="simple">novik-imt@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0665-8060</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титов</surname><given-names>Евгений Алексеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Titov</surname><given-names>Evgeny A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канд. биол. наук, ст. науч. сотр. лаб. биомоделирования и трансляционной медицины ФГБНУ ВСИМЭИ, 665826, Ангарск, Россия</p><p>e-mail: g57097@yandex.ru</p></bio><bio xml:lang="en"><p>PhD (Biology), senior researcher, Laboratory of biomodeling and translational medicine, East Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russia</p><p>e-mail: g57097@yandex.ru</p></bio><email xlink:type="simple">g57097@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6012-0173</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панкова</surname><given-names>Анна Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Pankova</surname><given-names>Anna A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мл. науч. сотр. лаб. биомоделирования и трансляционной медицины ФГБНУ ВСИМЭИ, 665826, Ангарск, Россия</p><p>e-mail: nyuta.pankova.96@mail.ru</p></bio><bio xml:lang="en"><p>Junior researcher at the Laboratory of biomodeling and translational Medicine, East Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation</p><p>e-mail: nyuta.pankova.96@mail.ru</p></bio><email xlink:type="simple">nyuta.pankova.96@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0876-2304</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лисецкая</surname><given-names>Людмила Гавриловна</given-names></name><name name-style="western" xml:lang="en"><surname>Lisetskaya</surname><given-names>Lyudmila G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канд. биол. наук, науч. сотр. лаб. аналитической экотоксикологии и биомониторинга ФГБНУ ВСИМЭИ, 665826, Ангарск, Россия</p><p>e-mail: lis_lu154@mail.ru</p></bio><bio xml:lang="en"><p>PhD (Biology), researcher, Laboratory of analytical ecotoxicology and biomonitoring, East Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation</p><p>e-mail: lis_lu154@mail.ru</p></bio><email xlink:type="simple">lis_lu154@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1052-4601</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соседова</surname><given-names>Лариса Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Sosedova</surname><given-names>Larisa M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, профессор, зав. лаб. биомоделирования и трансляционной медицины ФГБНУ ВСИМЭИ, 665826, Ангарск, Россия</p><p>e-mail: sosedlar@mail.ru</p></bio><bio xml:lang="en"><p>DSc (Medicine), professor, head, Laboratory of biomodeling and translational medicine, East Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation</p><p>e-mail: sosedlar@mail.ru</p></bio><email xlink:type="simple">sosedlar@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Восточно-Сибирский институт медико-экологических исследований</institution><country>Россия</country></aff><aff xml:lang="en"><institution>East Siberian Institute of Medical and Environmental Research</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2025</year></pub-date><volume>104</volume><issue>11</issue><fpage>1545</fpage><lpage>1548</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Новиков М.А., Титов Е.А., Панкова А.А., Лисецкая Л.Г., Соседова Л.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Новиков М.А., Титов Е.А., Панкова А.А., Лисецкая Л.Г., Соседова Л.М.</copyright-holder><copyright-holder xml:lang="en">Novikov M.A., Titov E.A., Pankova A.A., Lisetskaya L.G., Sosedova L.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/5307">https://www.rjhas.ru/jour/article/view/5307</self-uri><abstract><sec><title>Введение</title><p>Введение. Одно из перспективных направлений нанотоксикологии – изучение воздействия на живой организм наночастиц гадолиния. В этих исследованиях применяют высокомолекулярные соединения, например, арабиногалактан лиственницы сибирской, стабилизирующий наночастицы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В эксперименте было проведено подострое (в течение 10 дней) внутрижелудочное воздействие на беспородных половозрелых белых крыс-самцов (n = 96) нанокомпозитом гадолиния, инкапсулированным в природную полимерную матрицу арабиногалактана, в дозах 500 мкг/кг массы тела и 5000 мкг/кг массы тела. Исследование выполняли в два этапа – сразу после окончания затравки (ранний период) и через шесть месяцев после окончания экспонирования (отдалённый период). Для установления гонадотоксичности выполняли гистологический анализ тканей сперматогонного эпителия, морфометрическое определение генерального показателя функциональной активности семенников – индекса сперматогенеза.</p></sec><sec><title>Результаты</title><p>Результаты. Нанокомпозит гадолиния в дозах 500 и 5000 мкг/кг м. т. оказывал гонадотоксическое действие на репродуктивную систему крыс-самцов, выраженное в деструкции герминативного эпителия семенных канальцев с нарушением нормального процесса сперматогенеза. При этом в отдалённом периоде показатели к норме не возвращались. Экспериментально установлено, что наночастицы гадолиния способны проникать через гематотестикулярный барьер, накапливаясь в тканях семенников.</p></sec><sec><title>Ограничения исследования</title><p>Ограничения исследования. Количество животных и набор методик были достаточными для изучения воздействия на структурно-функциональное состояние ткани семенников наночастиц гадолиния, инкапсулированного в полисахарид арабиногалактан.</p></sec><sec><title>Заключение</title><p>Заключение. При подостром воздействии наночастиц гадолиния, инкапсулированных в матрицу арабиногалактана, установлено их гонадотоксическое действие на мужскую репродуктивную систему, выражающееся в структурно-функциональных изменениях ткани семенников.</p><p>Соблюдение этических стандартов. Работа выполнена в соответствии с протоколом экспериментальных исследований, принципами, изложенными в Европейской конвенции о защите позвоночных животных, используемых для экспериментов или в иных научных целях ETS № 123, ГОСТ 33215–2014 «Руководство по содержанию и уходу за лабораторными животными. Правила оборудования помещений и организации процедур», Recommendations for euthanasia of experimental animals: Part 1, Part 2. На проведение исследований получено разрешение Локального этического комитета (протокол № 8 от 15.12.2023 г.).</p></sec><sec><title>Участие авторов</title><p>Участие авторов: Новиков М.А. – концепция и дизайн исследования, обработка данных, редактирование, написание текста; Титов Е.А. – концепция и дизайн исследования, редактирование; Панкова А.А. – сбор материала и обработка данных; Лисецкая Л.Г. – обработка данных; Соседова Л.М. – концепция и дизайн исследования, редактирование, написание текста. Все соавторы – утверждение окончательного варианта статьи, ответственность за целостность всех её частей.</p></sec><sec><title>Благодарности</title><p>Благодарности. Коллектив авторов благодарит зав. лаб. функциональных наноматериалов ФИЦ ИрИХ СО РАН доктора хим. наук Титову Ю.Ю. за помощь в определении размерных характеристик наночастиц гадолиния.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование выполнено в рамках государственного задания ФГБНУ ВСИМЭИ.</p></sec><sec><title>Поступила</title><p>Поступила: 12.09.2025 / Принята к печати: 03.11.2025 / Опубликована: 19.12.2025</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. A promising direction of nanotoxicology is the study of the effect of gadolinium nanoparticles on the body, which is possible using high-molecular compounds, for example, Siberian larch arabinogalactan, which has a stabilizing effect on nanoparticles.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. As part of experimental studies, subacute (within 10 days) intragastric effects were carried out on outbred sexually mature male white rats (sixty four individuals) of gadolinium nanocomposite encapsulated in a natural polymer matrix of arabinogalactan at a dose of 500 µg/kg body weight and 5000 µg/kg body weight, respectively. The examination took place in 2 stages: immediately after the end of the seed (early period) and 6 months after the end of the exposure (long-term period). The work used a set of studies aimed at determining gonadotoxicity – histological examination of the tissues of the spermatogenic epithelium, morphometrically determined the general indicator of functional activity of the testes – the index of spermatogenesis.</p></sec><sec><title>Results</title><p>Results. Based on the conducted experimental studies, there has been established gonadotoxic effect of gadolinium nanoparticles on the reproductive system in male rats, expressed in the destruction of the germinal epithelium of the seminal tubules with a violation of the normal process of spermatogenesis with the administration of both doses of the studied nanocomposite, while in the long term the indicators do not return to normal. Also gadolinium nanoparticles have been established to be able to penetrate the hemato-testicular barrier, accumulating in testicular tissues.</p></sec><sec><title>Limitations</title><p>Limitations. The number of animals and the set of techniques is sufficient to study the effects of gadolinium nanoparticles encapsulated in the polysaccharide arabinogalactan on the structural and functional state of testicular tissue. </p></sec><sec><title>Conclusion</title><p>Conclusion. With subacute exposure to gadolinium nanoparticles encapsulated in an arabinogalactan matrix, there has been established their gonadotoxic effect on the male reproductive system, expressed by structural and functional changes in testicular tissue.</p><p>Compliance with ethical standards. The work was carried out in accordance with the protocol of experimental research, the principles set out in the European Convention for the Protection of Vertebrate Animals Used for Experiments or Other Scientific Purposes ETS No. 123, GOST 33215-2014 “Guidelines for the care and care of laboratory animals. Rules of equipment of premises and organization of procedures”, Recommendations for euthanasia of experimental animals: Part 1, Part 2. Permission was obtained from the Local Ethics Committee to conduct research (Protocol No. 8 dated 12/15/2023). </p></sec><sec><title>Contribution</title><p>Contribution: Novikov M.A. – concept and design of research, data processing, editing, writing text; Titov E.A. – concept and design of research, editing; Pankova A.A. – collection of material and data processing; Lisetskaya L.G. – data processing; Sosedova L.M. – concept and design of research, editing, writing text. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.</p></sec><sec><title>Acknowledgment</title><p>Acknowledgment. The team of authors would like to thank Yu.Y. Titova, Head of the Laboratory of functional nanomaterials of the Federal Research Center “A.E. Favorsky Irkutsk Institute of Chemistry’, the Siberian Branch of the Russian Academy of Sciences for her help in conducting research to determine the dimensional characteristics of gadolinium nanoparticles.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Funding</title><p>Funding. The study was carried out within the framework of the state assignment of the East Siberian Institute of Medical and Environmental Research.</p></sec><sec><title>Received</title><p>Received: September 12, 2025 / Accepted: November 3, 2025 / Published: December 19, 2025</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>наночастицы</kwd><kwd>гадолиний</kwd><kwd>семенники</kwd><kwd>гонадотоксичность</kwd><kwd>морфология</kwd><kwd>гистология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nanoparticles</kwd><kwd>gadolinium</kwd><kwd>testes</kwd><kwd>gonadotoxicity</kwd><kwd>morphology</kwd><kwd>histology</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bendszus M., Laghi A., Munuera J., Tanenbaum L.N., Taouli B., Thoeny H.C. MRI gadolinium-based contrast media: meeting radiological, clinical, and environmental needs. J. Magn. Reson. Imaging. 2024; 60(5): 1774–85. https://doi.org/10.1002/jmri.29181</mixed-citation><mixed-citation xml:lang="en">Bendszus M., Laghi A., Munuera J., Tanenbaum L.N., Taouli B., Thoeny H.C. MRI gadolinium-based contrast media: meeting radiological, clinical, and environmental needs. J. Magn. Reson. Imaging. 2024; 60(5): 1774–85. https://doi.org/10.1002/jmri.29181</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Goullé J.P., Cattanéo A., Saussereau E., Mahieu L., Guerbet M., Lacroix C. MRI gadolinium-based contrast agents. Radiologists beware! Ann. Pharm. Fr. 2009; 67(5): 335–9. https://doi.org/10.1016/j.pharma.2009.06.002</mixed-citation><mixed-citation xml:lang="en">Goullé J.P., Cattanéo A., Saussereau E., Mahieu L., Guerbet M., Lacroix C. MRI gadolinium-based contrast agents. Radiologists beware! Ann. Pharm. Fr. 2009; 67(5): 335–9. https://doi.org/10.1016/j.pharma.2009.06.002</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Starekova J., Pirasteh A., Reeder S.B. Update on gadolinium-based contrast agent safety, from the AJR special series on contrast media. AJR Am. J. Roentgenol. 2024; 223(3): e2330036. https://doi.org/10.2214/AJR.23.30036</mixed-citation><mixed-citation xml:lang="en">Starekova J., Pirasteh A., Reeder S.B. Update on gadolinium-based contrast agent safety, from the AJR special series on contrast media. AJR Am. J. Roentgenol. 2024; 223(3): e2330036. https://doi.org/10.2214/AJR.23.30036</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Le Fur M., Caravan P. The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists. Metallomics. 2019; 11(2): 240–54. https://doi.org/10.1039/c8mt00302e</mixed-citation><mixed-citation xml:lang="en">Le Fur M., Caravan P. The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists. Metallomics. 2019; 11(2): 240–54. https://doi.org/10.1039/c8mt00302e</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Akgun H., Gonlusen G., Cartwright J. Jr., Suki W.N., Truong L.D. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch. Pathol. Lab. Med. 2006; 130(9): 1354–7. https://doi.org/10.5858/2006-130-1354-agcmna</mixed-citation><mixed-citation xml:lang="en">Akgun H., Gonlusen G., Cartwright J. Jr., Suki W.N., Truong L.D. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch. Pathol. Lab. Med. 2006; 130(9): 1354–7. https://doi.org/10.5858/2006-130-1354-agcmna</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hui F.K., Mullins M. Persistence of gadolinium contrast enhancement inCSF: a possible harbinger of gadolinium neurotoxicity? Am. J. Neuroradiol. 2009; 30(1): E1. https://doi.org/10.3174/ajnr.A1205.</mixed-citation><mixed-citation xml:lang="en">Hui F.K., Mullins M. Persistence of gadolinium contrast enhancement inCSF: a possible harbinger of gadolinium neurotoxicity? Am. J. Neuroradiol. 2009; 30(1): E1. https://doi.org/10.3174/ajnr.A1205.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S., Jiang Y., Liu P., Yi Y., Hou D., Li Y., et al. Single-atom gadolinium nano-contrast agents with high stability for tumor T1 magnetic resonance imaging. ACS Nano. 2023; 17(9): 8053–63. https://doi.org/10.1021/acsnano.2c09664</mixed-citation><mixed-citation xml:lang="en">Liu S., Jiang Y., Liu P., Yi Y., Hou D., Li Y., et al. Single-atom gadolinium nano-contrast agents with high stability for tumor T1 magnetic resonance imaging. ACS Nano. 2023; 17(9): 8053–63. https://doi.org/10.1021/acsnano.2c09664</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Babič A., Vorobiev V., Trefalt G., Crowe LA., Helm L., Vallée J.P., et al. MRI micelles self-assembled from synthetic gadolinium-based nano building blocks. Chem. Commun. (Camb). 2019; 55(7): 945–8. https://doi.org/10.1039/c8cc08875f</mixed-citation><mixed-citation xml:lang="en">Babič A., Vorobiev V., Trefalt G., Crowe LA., Helm L., Vallée J.P., et al. MRI micelles self-assembled from synthetic gadolinium-based nano building blocks. Chem. Commun. (Camb). 2019; 55(7): 945–8. https://doi.org/10.1039/c8cc08875f</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chargari C., Maury P., Texier M., Genestie C., Morice P., Bockel S., et al. Theragnostic gadolinium-based nanoparticles safely augment x-ray radiation effects in patients with cervical cancer. ACS Nano. 2024; 18(26): 16516–29. https://doi.org/10.1021/acsnano.3c12537</mixed-citation><mixed-citation xml:lang="en">Chargari C., Maury P., Texier M., Genestie C., Morice P., Bockel S., et al. Theragnostic gadolinium-based nanoparticles safely augment x-ray radiation effects in patients with cervical cancer. ACS Nano. 2024; 18(26): 16516–29. https://doi.org/10.1021/acsnano.3c12537</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly G.S. Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern. Med. Rev. 1999; 4(2): 96–103.</mixed-citation><mixed-citation xml:lang="en">Kelly G.S. Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern. Med. Rev. 1999; 4(2): 96–103.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Novikov M.A., Titov E.A., Sosedova L.M., Rukavishnikov V.S., Vokina V.A., Lakhman O.L. Comparative assessment of silver nanocomposites’ biological effects on the natural and synthetic matrix. Int. J. Mol. Sci. 2021; 22(24): 13257. https://doi.org/10.3390/ijms222413257</mixed-citation><mixed-citation xml:lang="en">Novikov M.A., Titov E.A., Sosedova L.M., Rukavishnikov V.S., Vokina V.A., Lakhman O.L. Comparative assessment of silver nanocomposites’ biological effects on the natural and synthetic matrix. Int. J. Mol. Sci. 2021; 22(24): 13257. https://doi.org/10.3390/ijms222413257</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang C., Shi C., Chang P., Bian S., Li B., Li J., et al. MRI directed Magnevist effective to study toxicity of Gd-Doped mesoporous carbon nanoparticles in mice model. Int. J. Nanomedicine. 2023; 18: 6119–36. https://doi.org/10.2147/ijn.s433213</mixed-citation><mixed-citation xml:lang="en">Zhang C., Shi C., Chang P., Bian S., Li B., Li J., et al. MRI directed Magnevist effective to study toxicity of Gd-Doped mesoporous carbon nanoparticles in mice model. Int. J. Nanomedicine. 2023; 18: 6119–36. https://doi.org/10.2147/ijn.s433213</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Korolenko T.A., Dergunova M.A., Alekseenko T.V., Zhanaeva S.Y., Filyushina E.E., Filatova T.G. Intralysosomal accumulation of gadolinium and lysosomal damage during selective depression of liver macrophages in vivo. Bull. Exp. Biol. Med. 2006; 142(4): 391–4. https://doi.org/10.1007/s10517-006-0373-z</mixed-citation><mixed-citation xml:lang="en">Korolenko T.A., Dergunova M.A., Alekseenko T.V., Zhanaeva S.Y., Filyushina E.E., Filatova T.G. Intralysosomal accumulation of gadolinium and lysosomal damage during selective depression of liver macrophages in vivo. Bull. Exp. Biol. Med. 2006; 142(4): 391–4. https://doi.org/10.1007/s10517-006-0373-z</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков М.А., Титов Е.А., Якимова Н.Л., Вокина В.А., Панкова А.А., Скрынник А.С. и др. Оценка нейротоксичности нанокомпозита гадолиния. Гигиена и санитария. 2024; 103(11): 1423–8. https://doi.org/10.47470/0016-9900-2024-103-11-1423-1428 https://elibrary.ru/ozbxtk</mixed-citation><mixed-citation xml:lang="en">Novikov M.A., Titov E.A., Yakimova N.L., Vokina V.A., Pankova A.A., Skrynnik A.S. Assessment of neurotoxicity of gadolinium nanocomposite. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2024; 103(11): 1423–8. https://doi.org/10.47470/0016-9900-2024-103-11-1423-1428 https://elibrary.ru/ozbxtk (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Сухов Б.Г., Конькова Т.В., Титова Ю.Ю., Иванов А.В. Нанокомпозиты на основе гадолинийсодержащих соединений для диагностики, терапии и тераностики онкологических заболеваний головного мозга и способы их получения. Патент РФ № 2778928; 2022.</mixed-citation><mixed-citation xml:lang="en">Sukhov B.G., Konkova T.V., Titova Yu.Y., Ivanov A.V. Nanocomposites based on gadolinium-containing compounds for diagnosis, therapy and theranostics of oncological diseases of the brain and methods of their preparation. RF Patent No. 2778928; 2022. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rukavishnikov V.S., Novikov M.A., Titov E.A., Sosedova L.M., Yakimova N.L. Estimation of toxic properties of nanocomposites containing nanoparticles of bismuth, gadolinium, and silver. Тrace Elem. Electroly. 2018; 35: 203–6. https://doi.org/10.5414/TEX0155408</mixed-citation><mixed-citation xml:lang="en">Rukavishnikov V.S., Novikov M.A., Titov E.A., Sosedova L.M., Yakimova N.L. Estimation of toxic properties of nanocomposites containing nanoparticles of bismuth, gadolinium, and silver. Тrace Elem. Electroly. 2018; 35: 203–6. https://doi.org/10.5414/TEX0155408</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Методы экспериментального исследования по установлению порогов действия промышленных ядов на генеративную функцию с целью гигиенического нормирования. Методические рекомендации. М.: Наука; 1978.</mixed-citation><mixed-citation xml:lang="en">Experimental research methods for setting thresholds for the effect of industrial poisons on generative function for the purpose of hygienic rationing: Methodological recommendations. Moscow: Nauka; 1978. (in Russian)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
